Synopsis

25
Objectives: The goal of the present study was to obtain a comprehensive overview of 26 the bacteriostatic and bactericidal effects of six commonly used antibiotics on 27 planktonic as well as on sessile Burkholderia cepacia complex cells. 28 29 
31
Methods: The bacteriostatic and bactericidal activities of ceftazidime, ciprofloxacin, meropenem, minocycline, tobramycin and trimethoprim-sulfamethoxazole were determined on 38 B. cepacia complex strains. MICs and minimal biofilm inhibitory concentrations (MBICs) were determined using a traditional broth microdilution 32 method and a novel resazurin-based viability staining, respectively. The bactericidal 33 effects of the investigated antibiotics (using antibiotic concentrations corresponding to 34 10 x MIC; except for tobramycin, for which a final concentration of 4 x MIC was tested) 35 on stationary phase planktonic cultures and on 24 h old biofilms were evaluated using conventional plate count methods. Burkholderia cepacia complex bacteria are opportunistic pathogens that can cause severe infections in patients with cystic fibrosis (CF) or chronic granulomatous disease (CGD) and in immunocompromised individuals. 1 The taxonomy of the genus Burkholderia has undergone several major revisions over the last decades. In the mid-1990s, "Burkholderia cepacia" strains were demonstrated to belong to at least five distinct species, which were collectively referred to as the B. cepacia complex. 2 Further taxonomic analyses revealed that even more species were present within the B. cepacia complex and currently 17 B. cepacia complex species have been described. [2] [3] [4] [5] Except for Burkholderia ubonensis, all of these species have been isolated from sputum of CF patients, 4, 5 with Burkholderia cenocepacia and Burkholderia multivorans being predominant. 6 Infections with B. cepacia complex bacteria in CF patients are often correlated with increased morbidity and mortality and the innate resistance of these organisms to a broad range of antibiotics complicates the treatment of infected patients. panresistance is caused by various mechanisms, including limited permeability, changes in lipopolysaccharide structure and the presence of several multidrug efflux pumps, inducible chromosomal beta-lactamases and altered penicillin-binding proteins. 9 In addition, in vitro biofilm formation has been described for multiple B.
cepacia complex strains and this may contribute to their ability to survive in the CF lung environment by providing additional protection from antibiotics. 17, 18 In addition, bacterial cells may reside in biofilms. These consortia of microbial cells are embedded in a matrix of self-produced extracellular components and they are considered to exhibit an increased resistance compared to their free-floating planktonic counterparts. 19 Finally, inactivation of antibiotics in sputum or insufficient antibiotic concentrations in sputum, might also contribute to a poor in vivo activity despite a satisfactory in vitro activity. 20 The first objective of the present study was to evaluate the growth inhibitory effect of 
Determination of the MIC
MICs were determined in duplo according to the EUCAST broth microdilution protocol using flat-bottomed 96-well microtitre plates (TPP, Trasadingen, 130 Switzerland). 21 The range of antibiotic concentrations was from 0.25 mg/L to 128 131 mg/L for ceftazidime, ciprofloxacin, meropenem and minocycline; for tobramycin, 132 Enterobacteriaceae were used to evaluate the MIC results. 16 An adapted breakpoint 142 MIC of 256 mg/L was also included for tobramycin. In order to determine the growth inhibitory effects of the antibiotics on freshly 146 adhered sessile cells, a novel non-standard method using a resazurin-based viability 147 staining was applied. 22 The MBIC was defined as the minimum concentration of 148 
Results
MIC and MBIC experiments
The results of the broth microdilution MIC tests are shown in Table 1 The bactericidal effect of all antibiotics was determined on stationary phase 246 planktonic cultures, which were grown for 24 h, as well as on 24 h old biofilms. In 247 addition, the bactericidal effect of tobramycin on older planktonic cultures and 248 biofilms (grown for 76 h or for 100 h) was also determined for three selected strains 249 
Discussion
Antibiotic resistance is considered an important virulence factor of B. cepacia complex organisms. 1 Although therapy is usually guided by antimicrobial susceptibility testing, eradication of B. cepacia complex organisms is rarely achieved. 24 Multiple hypotheses have been formulated to explain this failure, including inadequate antibiotic concentrations or inactivation of the antibiotic in sputum, impaired host defences in CF patients, biofilm formation, 'inoculum' effect and in vivo growth rate of these organisms. 18 In the present study, we have focussed on the growth inhibitory and bactericidal effects of ceftazidime, ciprofloxacin, meropenem, minocycline, tobramycin and trimethoprim-sulfamethoxazole on 38 B. cepacia complex strains belonging to 17 species. In order to evaluate a possible increase in resistance towards tobramycin in older 366 biofilms and planktonic cultures compared to their younger counterparts, we also 367 determined the bactericidal effect of tobramycin on biofilms and planktonic cultures 368 grown for 76 h and 100 h. In previous studies on the susceptibility of P. aeruginosabiofilms, an increased resistance of older biofilms against this antibiotic was 370 reported. 33 Yet, in the present study no meaningful differences in susceptibility 371 between the older biofilms and planktonic cultures, on the one hand, and their 372 younger counterparts, on the other hand, were observed ( Figure 5) . A possible 373 explanation for this unexpected result may lie in the differences of the used growth 374 conditions and consequently, in the differences in observed growth patterns. Unlike 375 in some previous studies, cell numbers did not increase further in the older B. 376 cepacia complex biofilms compared to the younger biofilms (grown after 24 h). 33, 34 
377
In fact, the impact of these variations in growth pattern, which are the result of 378 differences in nutritional limitations, can influence greatly the susceptibility to 379 antibiotics. 
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